CanSino Biologics
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (33)
A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)
Started: 11/14/2025
Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine
Started: 3/23/2025
A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds
Started: 3/1/2024
A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 7 to 17 Year Olds
Started: 12/14/2024
A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population
Started: 9/16/2023
A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 Years
Started: 3/20/2024
A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)
Started: 8/11/2023
A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over
Started: 3/20/2024
Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)
Started: 4/13/2021
IH Convidecia as Second Booster Dose Against Breakthrough Infections
Started: 9/20/2022
Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)
Started: 12/15/2021
A Study to Evaluate the Safety and Immunogenicity of Ad5-vector Based Vaccine Against Coronavirus Variants in Adults (≥18 Years) Immunized With 2 Doses of mRNA Vaccines Plus One Dose of Booster AZD1222 Vaccine
Started: 11/30/2022
A Study to Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and Adolescents
Started: 2/25/2022
Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above
Started: 9/15/2020
A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)
Started: 12/20/2024
Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older
Started: 7/6/2022
A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
Started: 9/24/2020
Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine
Started: 12/19/2025
A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers
Started: 12/19/2024
A Study to Evaluate the Safety and Immunogenicity of Ad5-105K in Adults Aged 18 to 49 Years
Started: 11/13/2025
Clinical Trial of Lyophilized Haemophilus Influenzae Type b Conjugate Vaccine
Started: 11/15/2024
A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)
Started: 12/6/2023
Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older
Started: 5/17/2022
Clinical Trial of Recombinant Pneumococcal Protein Vaccine
Started: 3/11/2023
A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults
Started: 1/15/2024
A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years
Started: 11/7/2023
A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over
Started: 12/20/2023
Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation
Started: 4/21/2021
Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above
Started: 5/18/2020
Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed .
Started: 4/28/2020
Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults
Started: 3/16/2020
Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)
Started: 9/20/2023
Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants
Started: 6/12/2024